Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency
Thrombosis and Haemostasis · 01.08.2026 · 126 (08) · 809-818
DOI: 10.1055/a-2778-4440 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2026. Verfasst von Pablo García-Jaén und 26 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Hematología, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universi…. Hauptthemen laut MEDLINE: Blood Loss, Surgical, Factor VII Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Castellano-Leonesa de Hematología y Hemoterapia, Gerencia Regional de Salud Castilla y León, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Inherited factor VII deficiency (FVIID) presents a highly variable bleeding phenotype. The weak correlation between plasma FVII levels (FVII:C) and bleeding severity results in diverse management strategies and complicates surgical decision-making. To describe surgical management and bleeding outcomes in patients with FVIID, and to identify key decision-making variables and predictors of surgical bleeding. We conducted a multicenter, retrospective study of 380 surgeries performed in 215 patients with FVIID. Patients were classified by FVII:C levels as mild, moderate, or severe deficiency. Bleeding score (BS) was defined according to ISTH-BAT. Surgeries were categorized as low-moderate risk (LR) or high risk (HR) for bleeding. A decision-tree simulation was performed. Most patients had mild FVIID (76%), and 68% of surgeries were classified as LR. Prophylactic treatment with tranexamic acid (TA) and/or rFVIIa was administered in 42.8% of LR and 62.8% of HR surgeries. Prophylaxis was given to 73.9% of moderate/severe and 41% of mild FVIID patients, especially for HR procedures. FVII:C levels and surgical bleeding risk were key factors that influenced the selection of treatment. The overall bleeding rate was 3.1% (HR: 9%; LR: 0.4%). Most bleeding events occurred in mild FVIID patients with BS ≥3. Our algorithm recommends hemostatic treatment for all moderate/severe, and for mild patients HR surgeries and LR procedures when BS is ≥3. FVII:C levels and surgery type influence prophylactic hemostatic treatment strategies. Patients with mild FVIID, higher BS, and no hemostatic treatment had a greater risk of bleeding. Bleeding score and procedural risk were identified as predictors of surgical bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Servicio de Hematología, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), Spain.
- Servicio de Hematología, Hospital Universitario La Paz, Madrid, Spain.
- Servicio de Hematología, Hospital Universitario Miguel Servet, Zaragoza, Spain.
- Servicio de Hematología, Hospital San Pedro de Alcántara, Cáceres, Spain.
- Servicio de Oncología Radioterápica, Complejo Asistencial Universitario de Salamanca (CAUSA), Spain.
- Departamento de Estadística, Universidad de Salamanca (USAL), Spain.
ORCID-Profile: José María Bastida
Förderung
- Fundación Castellano-Leonesa de Hematología y Hemoterapia
- Gerencia Regional de Salud Castilla y León
- Instituto de Salud Carlos III
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
Zitieren
APA
García-Jaén, P., Martín de Bustamante, J. M., Mendoza-Martínez, A., Galván-Platas, S., Monleón-Gil, R., Calzadilla-Román, K. S., Nicolás-Boluda, C., Rey-Bua, B., Puerta-Vázquez, C., Zapata-Tapia, E., Cortés-Rodríguez, M., Hortal, A., Martínez-Robles, V., Cebeira-Moro, M. J., García-Díaz, C., Rodríguez-Alén, A., Aguilar-Franco, C., Marcellini, S., Fernández-Fontecha, E. M., …, & Bastida, J. M. (2026). Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency. Thrombosis and Haemostasis, 126(08), 809-818. https://doi.org/10.1055/a-2778-4440
Vancouver
García-Jaén P, Martín de Bustamante JM, Mendoza-Martínez A, Galván-Platas S, Monleón-Gil R, Calzadilla-Román KS, et al. Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency. Thrombosis and Haemostasis. 2026;126(08):809-818. doi:10.1055/a-2778-4440
BibTeX
@article{GarcaJan2026,
author = {García-Jaén, Pablo and Martín de Bustamante, José Manuel and Mendoza-Martínez, Ana and Galván-Platas, Sara and Monleón-Gil, Rafael and Calzadilla-Román, Karla Susana and Nicolás-Boluda, Celia and Rey-Bua, Beatriz and Puerta-Vázquez, Carlos and Zapata-Tapia, Evelyn and Cortés-Rodríguez, María and Hortal, Ana and Martínez-Robles, Violeta and Cebeira-Moro, María José and García-Díaz, Covadonga and Rodríguez-Alén, Agustín and Aguilar-Franco, Carlos and Marcellini, Shally and Fernández-Fontecha, Elena María and Dávila-Valls, Julio and Valle-Herrero, Sandra and Benito, Rocío and Bermejo, Nuria and Calvo-Villas, José Manuel and Álvarez-Román, María Teresa and González-Porras, José Ramón and Bastida, José María},
title = {Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {08},
pages = {809--818},
doi = {10.1055/a-2778-4440}
}
EUVIMED